Poor consolidated income statements haunt local pharmaceutical firms
Published: 2004-05-12 07:00:00
Updated: 2004-05-12 07:00:00
Overall, major pharmaceutical firms' management conditions have been deteriorating amid protracted business slump and to make matters worse, their affiliated companies have been in the same fate as the parent firms, according to data released by Yakup Shinmoon.
The consolidated income statemen...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
